Advertisement
Screener

EQUILLIUM, INC. (EQ) Other Receivables, Net, Current

2.8 / 5 stars · 68/120 Roast Me

EQUILLIUM, INC. Other Receivables, Net, Current

EQUILLIUM, INC. (EQ) had Other Receivables, Net, Current of $108.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-25.

Financial Statements › Notes

us-gaap:OtherReceivablesNetCurrent · last filed 2026-03-25

  • 2025-12-31: Other Receivables, Net, Current $108.00K.
  • 2025-09-30: Other Receivables, Net, Current $123.00K.
  • 2025-06-30: Other Receivables, Net, Current $35.00K.
  • 2025-03-31: Other Receivables, Net, Current $73.00K.
Period endOther Receivables, Net, Current
2025-12-31$108.00K
10-K · filed 2026-03-25
2025-09-30$123.00K
10-Q · filed 2025-11-13
2025-06-30$35.00K
10-Q · filed 2025-08-14
2025-03-31$73.00K
10-Q · filed 2025-05-14
2024-12-31$178.00K
10-K · filed 2026-03-25
2024-09-30$275.00K
10-Q · filed 2024-11-13
2024-06-30$407.00K
10-Q · filed 2024-08-08
2024-03-31$487.00K
10-Q · filed 2024-05-09
2023-12-31$497.00K
10-K · filed 2025-03-27
2022-12-31$269.00K
10-K · filed 2024-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
GENELUX Corp (GNLX)United States$0.110B-3.83
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
ProMIS Neurosciences Inc. (PMN)$0.102B
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49